Tricylic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (MMP) inhibitors
申请人:——
公开号:US20040023953A1
公开(公告)日:2004-02-05
The invention relates to mercaptomethyl-substituted thiazolo[2,3-b]quinazolines, oxazolo[2,3-b]quinazolines and imidazolo[2,1-b]quinazolines.
It is the object of the invention to discover new matrix metalloproteinase inhibitors (MMP) and give a simple synthesis method.
The object is achieved by the production of the indicated compounds. By means of them it is possible to achieve progress using them as active substances in pharmaceutical preparations for treating diseases such as inflammatory responses of non-specific causes, sunburn and allergies.
Puar,M.S. et al., Indian Journal of Chemistry, 1964, vol. 2, p. 285 - 287